首页> 外文期刊>Biotechnology and Bioengineering >Large-scale expansion of feeder-free mouse embryonic stem cells serially passaged in stirred suspension bioreactors at low inoculation densities directly from cryopreservation
【24h】

Large-scale expansion of feeder-free mouse embryonic stem cells serially passaged in stirred suspension bioreactors at low inoculation densities directly from cryopreservation

机译:直接从冷冻保存的低接种密度,在搅拌悬浮液体反应器中连续传代饲喂饲养的小鼠胚胎干细胞的大规模扩张

获取原文
获取原文并翻译 | 示例
           

摘要

Embryonic stem cells (ESCs) have almost unlimited proliferation capacity in vitro and can retain the ability to contribute to all cell lineages, making them an ideal platform material for cell-based therapies. ESCs are traditionally cultured in static flasks on a feeder layer of murine embryonic fibroblast cells. Although sufficient to generate cells for research purposes, this approach is impractical to achieve large quantities for clinical applications. In this study, we have developed protocols that address a variety of challenges that currently bottleneck clinical translation of ESCs expanded in stirred suspension bioreactors. We demonstrated that mouse ESCs (mESCs) cryopreserved in the absence of feeder cells could be thawed directly into stirred suspension bioreactors at extremely low inoculation densities (100 cells/ml). These cells sustained proliferative capacity through multiple passages and various reactor sizes and geometries, producing clinically relevant numbers (10(9) cells) and maintaining pluripotency phenotypic and functional properties. Passages were completed in stirred suspension bioreactors of increasing scale, under defined batch conditions which greatly improved resource efficiency. Output mESCs were analyzed for pluripotency marker expression (SSEA-1, SOX-2, and Nanog) through flow cytometry, and spontaneous differentiation and teratoma analysis was used to demonstrate functional maintenance of pluripotency.
机译:胚胎干细胞(ESC)在体外具有几乎无限的增殖能力,可以保留对所有细胞谱系有助于贡献的能力,使其成为基于细胞疗法的理想平台材料。传统上,ESC在鼠胚胎成纤维细胞饲养层上的静态烧瓶中培养。虽然足以为研究目的产生细胞,但这种方法对于实现大量临床应用来说是不切实际的。在这项研究中,我们开发了解决各种挑战的协议,目前瓶颈临床翻译Escs在搅拌的悬浮生物反应器中膨胀。我们证明,在没有饲养细胞的情况下冷冻保存的小鼠ESC(MESCS)可以在极低的接种密度(100个细胞/ mL)下直接解冻入搅拌的悬浮生物反应器中。这些细胞通过多个通道和各种反应器尺寸和几何形状持续增殖能力,产生临床相关的数字(10(9)个细胞)并维持多能表型和功能性。在搅拌的悬浮液生物反应器中完成了阶段的搅拌生物反应器,在规定的批处理条件下大大提高了资源效率。通过流式细胞术分析输出MESCS以通过流式细胞术分析多能性标记表达(SSEA-1,SOX-2和NANOG),并且使用自发分化和畸胎瘤分析来证明多能性的功能性维持。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号